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Abstrak 
Leukemia merupakan keganasan yang paling banyak terjadi pada anak, melibatkan sumsum tulang dan organ 
lain seperti sistem saraf pusat, tulang dan sendi. Abnormalitas skeletal yang berhubungan dengan leukemia antara 
lain osteoporosis, reaksi periosteal, sklerosis reaktif. Osteoporosis dapat terjadi sebagai manifestasi klinis awal atau 
lanjutan pada anak leukemia. Tatalaksana osteoporosis tepat sangat penting karena dapat mempengaruhi kualitas 
hidup, dan dapat berdampak negative pada kemampuan aktivitas anak. Dilaporkan kasus leukemia dan osteoporosis 
pada anak perempuan usia 7 tahun dan 5 bulan, berdasarkan manifestasi klinis, pemeriksaan laboratorium, dan 
radiologi. Pasien ditatalaksana dengan pemberian vitamin D dan kalsium dengan luaran perbaikan klinis. 
Kata kunci: leukemia, osteoporosis, vitamin D 
 
Abstract 
Leukemia is the most common malignancy in childhood, affected primarily bone marrow and other organ such 
as central nervous system, bone and joint. Skeletal abnormalities associated with leukemia is osteoporosis, periosteal 
reaction, reactive sclerosis. Osteoporosis could happen as initial presentation or  late effect in survivors of childhood 
cancer. The treatment is important because affecting quality of life and has negative effect on the survivors ability to 
perform developmentally appropriate activities. Reported a case of 7 years and 5 months girl with leukemia and 
osteoporosis, diagnosed by clinical manifestation, laboratory examination and radiology. Patient given vitamin D and 
calcium and got clinical improvement.  
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INTRODUCTION 
Oteoporosis is a major public health problem 
worldwide and its prevalence is increasing. This 
morbidity burden has considerable medical, social and 
financial implications due to the fractures associated 
with the disease. Osteoporosis is a well-established 
clinical worldwide problem for adults. On the other 
hand, osteoporosis in children and adolescents is 
rather new and increasingly recognized with certain 
unique diagnostic and clinical challenges.
1 
 
Leukemias as the most common malignant 
neoplasms in childhood, accounting for approximately 
31% of all malignancies that occur in children younger  
than 15 yr of age. Although it is primarily a disease of 
bone marrow and peripheral blood, many other organ 
could be infiltrated by leukemic cells., such as 
genitourinary tract, central nervous system, cardiac, 
skin, gastrointestinal, bone and joint. Bone pain is one 
of the initial symptoms in 25% of patients. Skeletal 
abnormalities have been described in association with 
ALL, including osteoporosis, periosteal reaction, 
reactive sclerosis, lytic defects and vertebral 
compression fractures. It may result from direct 
leukemic infiltration of  the periosteum, bone infarction, 
or expansion of marrow cavity by leukemic cells.
2,3
 
Osteoporosis is currently receiving an 
increasing attention as an important initial presentation 
or  late effect in survivors of childhood cancer and its 
treatment because of their quality of life and its 
negative   effect  on  the  survivors  ability  to  perform  
Case Report 
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developmentally appropriate activities. Physician 
should aware of osteoporosis as one of skeletal 
manifestation occurs in leukemic patient. 
 
CASE 
Reported  a 7 years and 5 months old girl, 
hospitalized at Pediatric Ward of M.Djamil Hospital 
with chief complain lower extremities could not be 
moved since 10 months prior admission. She had 
been diagnosed with Acute Lymphoblastic Leukemia 
(ALL) L3 , and still had chemotherapy.   She fell down 
from bicycle 10 months prior admission, and her lower 
extremities could not be moved since then. Intermittent 
pain was felt on back and knees, but there was There 
was no swollen on knees either her back. History of 
fractures prior to this was unknown. There was no 
uncontrolled miction nor defecation. Both micturition 
and defecation were normal.  
On physical examination, general appearance 
was moderately ill, she was alert. Pulse rate at 100 
bpm regular, respiratory rate at 24 bpm, and body 
temperature at 37
0
 C. Body weight 16 kg, body height 
at 119 cm. Nutritional status based on CDC was 
undernourished. The conjunctiva was anemic, sclera 
was not icteric. Lymph nodes sized 0,3x0,3x0,3 was 
palpable on submandibula region. Chest symmetrical 
shape, no retraction, and no wheezing and rales. 
Regular heart rhythm, no murmur. Abdominal was 
supple, liver palpable ¼-¼, flat surface, sharp edge, 
chewy consistency. Spleen was not palpable. Bowel 
sound (+) normal. Puberty state was  A1M1P1. 
Peripheral acral was warm, and good capillary refilling 
time. Deformity on lumbar region was (-). Genu dextra 
and sinistra range of movement was 45
o
. Laboratory 
examination result; hemoglobin 9.2 g/dl, white blood 
cell was 4750/mm
3
, erythrocyte was 3,4 millions/mm
3
, 
platelet was 406.000/mm
3
, differential count 
0/1/2/25/72/0, Blast was not found, hematocrit 31%, 
reticulocyte 16 ‰, MCH 27 pq, MCV 91,17 fl, MCHC 
29,6%. Peripheral blood smear result; normochrome, 
anisositosis, polychromacy, nuclear erythrocyte was 
found 4/100 white blood cell. Sodium 145 mmol/l, 
potassium 3,9 mmol/l, calcium 9,8 mg/dl. Calcium ion 
1,13 mmol/l. Vitamin D-25 OH 15,6 ng/ml. 
 
Bone survey result was osteoporosis with 
multiple thoracolumbal vertebrae compression 
fractures. Patient diagnosed as  ALL L3 with 
osteoporosis. Treatment  on this patient; vitamin D 
1x1000 IU/day 8-12 weeks, calcium lactate 3x500 
mg/day, continue chemotherapy. Patient was 
consulted to Orthopedic Department and Medical 
Rehabilitation. After appropriate therapy, vitamin D 
was reevaluated. Vitamin D-25 OH was 30 ng/ml. 
Patient got improvement, she could walk by herself. 
 
DISCUSSION 
Patient diagnosed as acute lymphoblastic 
leukemia L3 with osteoporosis. Acute lymphoblastic 
leukemia was established based on clinical sign and 
several examination, such as peripheral blood 
examination and bone marrow puncture. Patient felt  
intermittent backache. Bone pain is one of the initial 
symptoms in 25% of patients, as in this case. It may 
result from direct leukemic infiltration of the 
periosteum, bone infarction, or expansion of marrow 
cavity by leukemic cells 
3 
About two-thirds of children 
with ALL will have had signs and symptoms of disease 
for less than 4 weeks at the time of diagnosis. 
However, a history of some months is also compatible 
with the diagnosis of ALL. The first symptoms are 
usually nonspecific and include lethargy, unrelenting 
fatigue, bone pain or loss of appetite.  Acute leukemia 
of childhood may present with various manifestations 
that mimic orthopedic conditions. Haddy et al reported 
a boy with spontaneous fractures as an intial 
symptomps of leukemia.
4 
Bone survey showed there was compacted 
fracture on spine and osteoporosis. Radiographic 
abnormalities in childhood ALL have been described in 
the literature for over 80 years. Radiologic changes 
occasionally seen include:  Osteolytic lesions involving 
medullary cavity and cortex; transverse metaphyseal 
radiolucent bands; transverse metaphyseal lines of 
increased density (growth arrest lines); subperiosteal 
new bone formation. 
3
 As noted by Halton et al the 
prevalence of severe vertebral compression fractures 
in children with newly diagnosed ALL is as high as 16 
%.
5
  Riccio  et al   reported  fifty-five  (75.3%)  patients  
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showed radiographic abnormalities, mostly 
osteoporosis in 22 patients (40%).
6
 Although back pain 
is a recognized complaint in children with vertebral 
fractures at ALL diagnosis, a significant proportion of 
these fractures (45 %) are asymptomatic, despite 
identified vertebral fractures on lateral spine imaging. 
4 
Laboratory examination revealed low calcium 
ion 1,13 mmol/l (Reference range 1,17-1,29 mmol/L), 
low Vitamin D-25 OH 15,6 ng/ml (Reference range 30-
100 ng/ml). There was several classification of Vitamin 
D deficiency according to each consensus as shown in 
Table 1. 
 
Table 1. Vitamin D status based on calcidiol 
concentrations 
7 
Vitamin D 
status 
Calcidiol (ng/ml) 
AAP 
2008, 
IOM 
Endocrine 
Society 
KDOQI Adult-
NEJM 
2007 
Severe 
Deficiency 
< 5 - <5 - 
Mild to 
moderate 
deficiency 
5-15 <20 5-15 <20 
Insufficiency 16-20 21-30 16-30 20-30 
Sufficiency 21-100 31-60 >30 31-60 
Excess 101-
149 
- - - 
Intoxixation >150 - - >150 
AAP, American Academy of Pediatrics; IOM, Institute od 
Medicine;KDOQI, Kidney Disease Outcomes Quality 
Initiative;NEJM, New England Journal of Medicine 
 
In a vitamin D deficient patient, the intestinal 
absorption of calcium and phosphorus is decreased. 
The parathyroid gland recognizes the low serum 
calcium concentrations and releases PTH to increase 
the serum calcium back into an adequate range. PTH 
increases the calcium reabsorption in the kidneys and 
the excretion of phosphorus, therefore decreasing the 
risk of complication from an elevated calcium 
phosphate product (e.g., kidney stones). While this 
reduction is protecting the body, it is also decreasing 
bone mineralization at the same time. Over weeks to 
months, osteomalacia, stunted growth, and rickets 
may develop.
7 
 
The 2 major forms of Vitamin D are vitamin D2 
(ergocalciferol) and vitamin D3 (cholecalciferol). 
Vitamins D2 and D3 are produced by photolysis with 
UVB (wavelength 280–315 nm) from sterol recursors. 
Certain plants and fungi produce vitamin D2, whereas 
vitamin D3 is synthesised by animals (eg, fish, birds, 
vertebrates) and within the human skin. Dietary 
vitamin D2 and D3 are absorbed in the small intestine. 
Absorption is dependent on the presence of dietary 
fats in the intestine to stimulate the production of 
pancreatic lipase and bile acids. Excretion of vitamin D 
metabolites takes place mainly through the bile, and to 
a much lesser extent through the urine.
8 
Vitamins D2 and D3 are both inactive 
prohormones that bind to the vitamin D–binding 
protein to be transported to the liver, where they are 
converted to 25-hydroxyvitamin D (25(OH)D) by the 
enzyme 25-hydroxylase. 25(OH)D undergoes further 
hydroxylation by the enzyme 1a-hydroxylase in the 
kidney to become the active metabolite 1,25-
dihydroxyvitamin D (1,25(OH)D). This second 
hydroxylation step is regulated by calcium and 
phosphate concentrations via parathyroid hormone 
(PTH). 1,25(OH)D is the active metabolite that is 
involved in many physiological processes, mainly, but 
not exclusively in calcium and phosphate metabolism.
8 
Dietary sources of vitamin D are scarce and 
include mainly fatty fish (wild salmon, mackerel, eel, 
anchovy, sardines, swordfish, tuna), and to a lesser 
extent, egg yolk and certain fungi. In some European 
countries, certain foods are fortified with vitamin D. 
These include milk, dairy products, margarine, 
breakfast cereals, and fruit juices.
 8
  In addition to 
dietary sources, children and adults obtain vitamin D 
through exposure to ultraviolet B sunlight. As little as 
10 to 15 minutes of direct sunlight can generate 
10,000 to 20,000 IU of vitamin D. Many factors 
influence vitamin D synthesis, such as skin 
pigmentation, latitude, and amount of skin exposed, 
making it difficult to assess how much vitamin D will be 
converted from sunlight exposure. .
9 
Patient consumed 
milk, egg, fish, and egg routinely. She also lived in 
area near the beach where sun exposure was quite 
high. 
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In efforts to achieve and maintain the target 
vitamin concentrations, the AAP recommends all 
infants, children, and adolescents should receive a 
minimum daily intake of 400 international units of 
vitamin D to prevent rickets and to maintain vitamin D 
concentrations at > 20 ng/mL (50 nmol/L). Term 
infants should be supplemented with 400 to 800 units 
daily to account for the insufficient transfer of maternal 
vitamin D stores and ensure calcidiol concentrations of 
> 20 ng/mL (50 nmol/L).  Vitamin D dose for 
prevention and treatment of vitamin D deficiency are 
listed in Table 2.  In addition to dietary sources, 
children and adults obtain vitamin D through exposure 
to ultraviolet B sunlight. As little as 10 to 15 minutes of 
direct sunlight cangenerate 10,000 to 20,000 IU of 
vitamin D. Many factors influence vitamin D synthesis, 
such as skin pigmentation, latitude, and amount of skin 
exposed, making it difficult to assess how much 
vitamin D will be converted from sunlight exposure. 
Infants and children who have darker pigmentation 
require five to 10 times the length. of sunlight exposure 
to reach the same levels of 25- hydroxyvitamin D when 
compared with children who have lighter pigmentation. 
However, the AAP recommends that infants younger 
than six months be kept out of direct sunlight .
9 
 
Table 2. Vitamin D dosing for prevention and 
treatment of nutritional vitamin D deficiency in 
children.
9 
   Vitamin D supplementation (Cholecalciferol) 
Prevention 400 IU/day 
Treatment < 1 month : 1000 IU/day for 2-3  
                    months 
1-12 months: 1000-5000 IU/day for  
                       2-3 months 
>12 months : 5000 IU/day for 2-3  
                      months 
 
The Endocrine Society Guideline recommend 
that nfants and children aged 0–1 yr require at least 
400IU/d (IU=25ng) of vitamin D and children 1 yr and 
older require at least 600 IU/d to maximize bone 
health. Whether 400 and 600 IU/d for children aged 0–
1 yr and 1–18 yr, respectively, are enough to provide 
all the potential nonskeletal health benefits associated 
with vitamin D to maximize bone health and muscle 
function is not known at this time. However, to raise 
the blood level of 25(OH)D consistently above 30 
ng/ml (75 nmol/liter) may require at least 1000 IU/d of 
vitamin D.
10
 Patient was given vitamin D 1000 IU given 
once daily for 8-12 weeks, and calcium 500 mg given 
3 times daily. 
Every child who has risk factor of developing 
osteoporosis should be done examination of Dual X 
Ray Absorptiometry (DXA) to define bone mass 
density. Even in child diagnosed with cancer, DXA 
should be done prior or off therapy, as stated in the 
algorithm above. We could not do DXA examination in 
this patient, because currently it is not available in 
Padang. 
Other treatment of osteoporosis is weight 
bearing exercise. Weight-bearing exercises can 
include aerobics, circuit training, jogging, jumping, 
volleyball and other sports that generate impact to the 
skeleton. There is evidence to suggest that the years 
of childhood and adolescence represent an 
opportunity period during which bone adapts 
particularly efficiently to such loading. Patient was 
done extremities traction to improve the contracture, 
but it lasted for a while, as patient could not bear the 
pain caused by traction. Medical rehabilitation 
suggested to do exercise on bilateral hip, that could be 
done at home by her mother. 
 
CONCLUSION 
Osteoporosis could occur in malignancy such 
as leukemia. Vitamin D and calcium have a big role in 
maintaining bone density. Every leukemia should be 
considered  having osteoporosis, regarding natural 
disease and chemotherapy. 
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